{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:54:35Z","timestamp":1786992875507,"version":"build-2736575974"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"am","delay-in-days":285,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI150461"],"award-info":[{"award-number":["AI150461"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI150466 AKG"],"award-info":[{"award-number":["AI150466 AKG"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006151","name":"Basic Energy Sciences","doi-asserted-by":"publisher","award":["W-31-109-Eng-38"],"award-info":[{"award-number":["W-31-109-Eng-38"]}],"id":[{"id":"10.13039\/100006151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008545","name":"Georgia State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jmgm.2022.108315","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T13:12:15Z","timestamp":1662037935000},"page":"108315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["HIV-1 protease with 10 lopinavir and darunavir resistance mutations exhibits altered inhibition, structural rearrangements and extreme dynamics"],"prefix":"10.1016","volume":"117","author":[{"given":"Andres","family":"Wong-Sam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Kneller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey Y.","family":"Kovalevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4876-7393","authenticated-orcid":false,"given":"Irene T.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jmgm.2022.108315_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2101016","article-title":"Cabotegravir for HIV prevention in cisgender men and transgender women","volume":"385","author":"Landovitz","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jmgm.2022.108315_bib4","first-page":"111","article-title":"2019 update of the drug resistance mutations in HIV-1","volume":"27","author":"Wensing","year":"2019","journal-title":"Top Antivir Med"},{"issue":"3","key":"10.1016\/j.jmgm.2022.108315_bib5","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/v1031209","article-title":"Current and novel inhibitors of HIV protease","volume":"1","author":"Pokorn\u00e1","year":"2009","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.jmgm.2022.108315_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2013.01.007","article-title":"Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments","volume":"98","author":"Men\u00e9ndez-Arias","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jmgm.2022.108315_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.virol.2015.03.021","article-title":"Retroviral proteases and their roles in virion maturation","volume":"479\u2013480","author":"Konvalinka","year":"2015","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.jmgm.2022.108315_bib9","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.tim.2016.03.010","article-title":"Improving viral protease inhibitors to counter drug resistance","volume":"24","author":"Kurt Yilmaz","year":"2016","journal-title":"Trends Microbiol."},{"issue":"Pt 8","key":"10.1016\/j.jmgm.2022.108315_bib10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1107\/S0907444907029125","article-title":"Conformational flexibility in the flap domains of ligand-free HIV protease","volume":"63","author":"Heaslet","year":"2007","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"34","key":"10.1016\/j.jmgm.2022.108315_bib11","doi-asserted-by":"crossref","first-page":"11956","DOI":"10.1021\/ja504096m","article-title":"Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease","volume":"136","author":"Ragland","year":"2014","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.jmgm.2022.108315_bib12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tips.2007.10.013","article-title":"HIV-1 protease inhibitors: effects on HIV-2 replication and resistance","volume":"29","author":"Men\u00e9ndez-Arias","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.jmgm.2022.108315_bib13","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.4155\/fmc.15.44","article-title":"Highly resistant HIV-1 proteases and strategies for their inhibition","volume":"7","author":"Weber","year":"2015","journal-title":"Future Med. Chem."},{"issue":"5","key":"10.1016\/j.jmgm.2022.108315_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/v13050839","article-title":"HIV protease: historical perspective and current research","volume":"13","author":"Weber","year":"2021","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.jmgm.2022.108315_bib15","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/febs.12743","article-title":"Thermodynamic and structural analysis of HIV protease resistance to darunavir - analysis of heavily mutated patient-derived HIV-1 proteases","volume":"281","author":"Koz\u00edsek","year":"2014","journal-title":"FEBS J."},{"issue":"11","key":"10.1016\/j.jmgm.2022.108315_bib16","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1021\/acschembio.9b00370","article-title":"Picomolar to micromolar: elucidating the role of distal mutations in HIV-1 protease in conferring drug resistance","volume":"14","author":"Henes","year":"2019","journal-title":"ACS Chem. Biol."},{"issue":"13","key":"10.1016\/j.jmgm.2022.108315_bib17","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1021\/bi2018317","article-title":"HIV-1 protease with 20 mutations exhibits extreme resistance to clinical inhibitors through coordinated structural rearrangements","volume":"51","author":"Agniswamy","year":"2012","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.jmgm.2022.108315_bib18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbrc.2011.08.045","article-title":"The higher barrier of darunavir and tipranavir resistance for HIV-1 protease","volume":"412","author":"Wang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"35","key":"10.1016\/j.jmgm.2022.108315_bib19","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1021\/acs.biochem.9b00446","article-title":"Molecular determinants of epistasis in HIV-1 protease: elucidating the interdependence of L89V and L90M mutations in resistance","volume":"58","author":"Henes","year":"2019","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.jmgm.2022.108315_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168616","article-title":"Structural studies of a rationally selected multi-drug resistant HIV-1 protease reveal synergistic effect of distal mutations on flap dynamics","volume":"11","author":"Agniswamy","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jmgm.2022.108315_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.108005","article-title":"Revertant mutation V48G alters conformational dynamics of highly drug resistant HIV protease PRS17","volume":"108","author":"Burnaman","year":"2021","journal-title":"J. Mol. Graph. Model."},{"issue":"15","key":"10.1016\/j.jmgm.2022.108315_bib22","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1111\/febs.15207","article-title":"Highly drug-resistant HIV-1 protease reveals decreased intra-subunit interactions due to clusters of mutations","volume":"287","author":"Kneller","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.jmgm.2022.108315_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jmgm.2015.09.006","article-title":"Conformational variation of an extreme drug resistant mutant of HIV protease","volume":"62","author":"Shen","year":"2015","journal-title":"J. Mol. Graph. Model."},{"issue":"13","key":"10.1016\/j.jmgm.2022.108315_bib24","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.jmb.2016.05.005","article-title":"Evolution under drug pressure remodels the folding free-energy landscape of mature HIV-1 protease","volume":"428","author":"Louis","year":"2016","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jmgm.2022.108315_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"Rhee","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"Suppl 1","key":"10.1016\/j.jmgm.2022.108315_bib26","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/505356","article-title":"Rationale and uses of a public HIV drug-resistance database","volume":"194","author":"Shafer","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.jmgm.2022.108315_bib27","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1128\/AAC.00574-10","article-title":"HIV-1 protease mutations and protease inhibitor cross-resistance","volume":"54","author":"Rhee","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"39","key":"10.1016\/j.jmgm.2022.108315_bib28","doi-asserted-by":"crossref","first-page":"12957","DOI":"10.1021\/bi960984y","article-title":"Influence of flanking sequences on the dimer stability of human immunodeficiency virus type 1 protease","volume":"35","author":"Wondrak","year":"1996","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.jmgm.2022.108315_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1432-1327.1999.00514.x","article-title":"Structural and kinetic analysis of drug resistant mutants of HIV-1 protease","volume":"263","author":"Mahalingam","year":"1999","journal-title":"Eur. J. Biochem."},{"issue":"5","key":"10.1016\/j.jmgm.2022.108315_bib30","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1021\/acsomega.9b00683","article-title":"Highly drug-resistant HIV-1 protease mutant PRS17 shows enhanced binding to substrate analogues","volume":"4","author":"Agniswamy","year":"2019","journal-title":"ACS Omega"},{"issue":"9","key":"10.1016\/j.jmgm.2022.108315_bib31","doi-asserted-by":"crossref","first-page":"12132","DOI":"10.1021\/acsomega.8b01683","article-title":"Drug resistance mutation L76V alters nonpolar interactions at the flap-core interface of HIV-1 protease","volume":"3","author":"Wong-Sam","year":"2018","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.jmgm.2022.108315_bib32","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.bbrc.2019.05.064","article-title":"Structural studies of antiviral inhibitor with HIV-1 protease bearing drug resistant substitutions of V32I, I47V and V82I","volume":"514","author":"Pawar","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"17","key":"10.1016\/j.jmgm.2022.108315_bib33","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/0960-894X(95)00330-V","article-title":"Estimating KI values for tight binding inhibitors from dose-response plots","volume":"5","author":"Copeland","year":"1995","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2022.108315_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"issue":"Pt 7","key":"10.1016\/j.jmgm.2022.108315_bib35","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1107\/S0907444903008126","article-title":"A graphical user interface to the CCP4 program suite","volume":"59","author":"Potterton","year":"2003","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 1","key":"10.1016\/j.jmgm.2022.108315_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1107\/S0907444909042589","article-title":"Molecular replacement with MOLREP","volume":"66","author":"Vagin","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 4","key":"10.1016\/j.jmgm.2022.108315_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"18","key":"10.1016\/j.jmgm.2022.108315_bib38","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/j.1742-4658.2010.07771.x","article-title":"Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters","volume":"277","author":"Shen","year":"2010","journal-title":"FEBS J."},{"issue":"Pt 1","key":"10.1016\/j.jmgm.2022.108315_bib39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr. A"},{"issue":"Pt 4","key":"10.1016\/j.jmgm.2022.108315_bib40","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 4","key":"10.1016\/j.jmgm.2022.108315_bib41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"issue":"Pt 3","key":"10.1016\/j.jmgm.2022.108315_bib42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.jmgm.2022.108315_bib43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0076-6879(97)77016-2","article-title":"Automated refinement for protein crystallography","volume":"277","author":"Lamzin","year":"1997","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.jmgm.2022.108315_bib44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jmb.2006.08.007","article-title":"Ultra-high resolution crystal structure of HIV-1 protease mutant reveals two binding sites for clinical inhibitor TMC114","volume":"363","author":"Kovalevsky","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2022.108315_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"Software"},{"issue":"1","key":"10.1016\/j.jmgm.2022.108315_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.jmgm.2022.108315_bib47","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"1","key":"10.1016\/j.jmgm.2022.108315_bib48","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"issue":"8","key":"10.1016\/j.jmgm.2022.108315_bib49","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"issue":"2","key":"10.1016\/j.jmgm.2022.108315_bib50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/00268978400101201","article-title":"A molecular dynamics method for simulations in the canonical ensemble","volume":"52","author":"Nos\u00e9","year":"1984","journal-title":"Mol. Phys."},{"issue":"3","key":"10.1016\/j.jmgm.2022.108315_bib51","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","article-title":"Canonical dynamics: equilibrium phase-space distributions","volume":"31","author":"Hoover","year":"1985","journal-title":"Phys Rev A Gen Phys"},{"issue":"12","key":"10.1016\/j.jmgm.2022.108315_bib52","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"issue":"12","key":"10.1016\/j.jmgm.2022.108315_bib53","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.jmgm.2022.108315_bib54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/ct700200b","article-title":"A parallel linear constraint solver for molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J. Chem. Theor. Comput."},{"issue":"12","key":"10.1016\/j.jmgm.2022.108315_bib55","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"1","key":"10.1016\/j.jmgm.2022.108315_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbrc.2019.08.126","article-title":"Potent antiviral HIV-1 protease inhibitor combats highly drug resistant mutant PR20","volume":"519","author":"Kneller","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"21","key":"10.1016\/j.jmgm.2022.108315_bib57","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1021\/bi200033z","article-title":"The L76V drug resistance mutation decreases the dimer stability and rate of autoprocessing of HIV-1 protease by reducing internal hydrophobic contacts","volume":"50","author":"Louis","year":"2011","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.jmgm.2022.108315_bib58","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1128\/JVI.02706-06","article-title":"Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations","volume":"81","author":"Muzammil","year":"2007","journal-title":"J. Virol."},{"issue":"9238","key":"10.1016\/j.jmgm.2022.108315_bib59","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(05)74270-7","article-title":"HIV\/AIDS epidemiology","volume":"356","author":"Todd","year":"2000","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jmgm.2022.108315_bib60","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/cmdc.201000318","article-title":"Probing multidrug-resistance and protein-ligand interactions with oxatricyclic designed ligands in HIV-1 protease inhibitors","volume":"5","author":"Ghosh","year":"2010","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.jmgm.2022.108315_bib61","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/jm301519z","article-title":"Novel P2 tris-tetrahydrofuran group in antiviral compound 1 (GRL-0519) fills the S2 binding pocket of selected mutants of HIV-1 protease","volume":"56","author":"Zhang","year":"2013","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.jmgm.2022.108315_bib62","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1021\/jm400231v","article-title":"Extreme multidrug resistant HIV-1 protease with 20 mutations is resistant to novel protease inhibitors with P1'-pyrrolidinone or P2-tris-tetrahydrofuran","volume":"56","author":"Agniswamy","year":"2013","journal-title":"J. Med. Chem."},{"issue":"Pt 6","key":"10.1016\/j.jmgm.2022.108315_bib63","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1107\/S0907444911011541","article-title":"Contribution of the 80s loop of HIV-1 protease to the multidrug-resistance mechanism: crystallographic study of MDR769 HIV-1 protease variants","volume":"67","author":"Yedidi","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"8","key":"10.1016\/j.jmgm.2022.108315_bib64","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1128\/AAC.00465-12","article-title":"Mutations in HIV-1 gag and pol compensate for the loss of viral fitness caused by a highly mutated protease","volume":"56","author":"Koz\u00edsek","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.jmgm.2022.108315_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12977-020-00520-6","article-title":"Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors","volume":"17","author":"Bastys","year":"2020","journal-title":"Retrovirology"},{"issue":"43","key":"10.1016\/j.jmgm.2022.108315_bib66","doi-asserted-by":"crossref","first-page":"22741","DOI":"10.1074\/jbc.M116.747568","article-title":"Effects of hinge-region natural polymorphisms on human immunodeficiency virus-type 1 protease structure, dynamics, and drug pressure evolution","volume":"291","author":"Liu","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.jmgm.2022.108315_bib67","doi-asserted-by":"crossref","first-page":"17203","DOI":"10.1074\/jbc.M114.571836","article-title":"The role of select subtype polymorphisms on HIV-1 protease conformational sampling and dynamics","volume":"289","author":"Huang","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jmgm.2022.108315_bib68","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jmb.2007.04.081","article-title":"Computational characterization of structural role of the non-active site mutation M36I of human immunodeficiency virus type 1 protease","volume":"370","author":"Ode","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.jmgm.2022.108315_bib69","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00894-006-0121-3","article-title":"Insights into amprenavir resistance in E35D HIV-1 protease mutation from molecular dynamics and binding free-energy calculations","volume":"13","author":"Meiselbach","year":"2007","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.jmgm.2022.108315_bib70","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fmicb.2016.00061","article-title":"Unique flap conformation in an HIV-1 protease with high-level darunavir resistance","volume":"7","author":"Nakashima","year":"2016","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.jmgm.2022.108315_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/v12111275","article-title":"Darunavir-resistant HIV-1 protease constructs uphold a conformational selection hypothesis for drug resistance","volume":"12","author":"Liu","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.jmgm.2022.108315_bib72","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/07391102.2015.1018326","article-title":"Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights","volume":"34","author":"Chetty","year":"2016","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"46","key":"10.1016\/j.jmgm.2022.108315_bib73","doi-asserted-by":"crossref","first-page":"E9855","DOI":"10.1073\/pnas.1716098114","article-title":"Binding kinetics and substrate selectivity in HIV-1 protease-Gag interactions probed at atomic resolution by chemical exchange NMR","volume":"114","author":"Deshmukh","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.jmgm.2022.108315_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040489","article-title":"Acquired HIV-1 protease conformational flexibility associated with lopinavir failure may shape the outcome of darunavir therapy after antiretroviral therapy switch","volume":"11","author":"Eche","year":"2021","journal-title":"Biomolecules"},{"issue":"18","key":"10.1016\/j.jmgm.2022.108315_bib75","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1093\/bioinformatics\/btz076","article-title":"Gag-protease coevolution shapes the outcome of lopinavir-inclusive treatment regimens in chronically infected HIV-1 subtype C patients","volume":"35","author":"Marie","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmgm.2022.108315_bib76","first-page":"1","article-title":"Understanding the co-evolutionary molecular mechanisms of resistance in the HIV-1 Gag and protease","author":"Marie","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"13","key":"10.1016\/j.jmgm.2022.108315_bib77","doi-asserted-by":"crossref","first-page":"6762","DOI":"10.1128\/JVI.00018-08","article-title":"Structural analysis of human immunodeficiency virus type 1 CRF01_AE protease in complex with the substrate p1-p6","volume":"82","author":"Bandaranayake","year":"2008","journal-title":"J. Virol."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326322001942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326322001942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:14:54Z","timestamp":1761081294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326322001942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":74,"alternative-id":["S1093326322001942"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2022.108315","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-1 protease with 10 lopinavir and darunavir resistance mutations exhibits altered inhibition, structural rearrangements and extreme dynamics","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2022.108315","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108315"}}